Cytomegalovirus Cell Mediated Immunity Clinical Trials in Houston, Texas

The Use of Cytomegalovirus Cell Mediated Immunity to Optimize the Duration of Letermovir Prophylaxis in Hematopoietic Cell Transplant Recipients